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Submicroscopic copy-number variations make a considerable contribution to the genetic etiology of human disease. We have analyzed
subjects with idiopathic mental retardation (MR) by using whole-genome oligonucleotide-based array comparative genomic hybridiza-
tion (aCGH) and identiﬁed familial and de novo recurrent Xp11.22-p11.23 duplications in males and females with MR, speech delay,
and a peculiar electroencephalographic (EEG) pattern in childhood. The size of the duplications ranges from 0.8–9.2 Mb. Most affected
females show preferential activation of the duplicated X chromosome. Carriers of the smallest duplication show X-linked recessive
inheritance. All other affected individuals present dominant expression and comparable clinical phenotypes irrespective of sex, dupli-
cation size, and X-inactivation pattern. The majority of the rearrangements are mediated by recombination between ﬂanking complex
segmental duplications. The identiﬁcation of common clinical features, including the typical EEG pattern, predisposing genomic struc-
ture, and peculiar X-inactivation pattern, suggests that duplication of Xp11.22-p11.23 constitutes a previously undescribed syndrome.Mental retardation (MR), deﬁned as cognitive impairment
with onset before the age of 18, affects 2%–3% of the pop-
ulation in Western countries.1 X-linked gene defects have
long been considered important causes of MR on the basis
of the observation that MR is signiﬁcantly more common
in males than in females.2 Large cohorts of well-character-
ized families have been crucial to the identiﬁcation of
X-linked MR (MRX) genes, and MR-causing inactivating
variants have now been described in about 10% of the
genes on the X chromosome.3 Autosomal and X-linked
dominant gene mutations and subtle chromosomal rear-
rangements also have an essential role in the etiology of
MR. Microarray-based comparative genomic hybridization
(CGH) is becoming themethod of choice for the identiﬁca-
tion of submicroscopic copy-number variations. In a recent
study using high-resolution tiling X-aCGH, causal struc-
tural aberrations were detected in 4.6% of patients with
idiopathic MR.4 The Xp11 region carries almost 30% of
all gene defects that underlie nonsyndromic MRX.5394 The American Journal of Human Genetics 85, 394–400, SeptemAs a result of a collaborative effort to share the results of
individual diagnostic laboratories, we compared anony-
mous aCGH results of individuals with syndromic as well
as nonsyndromic forms of MR. We screened 2400 subjects
with isolated or syndromic MR for copy-number changes
by whole-genome aCGH. Genomic DNA was extracted
from probands’ blood, EBV cell lines, and parents’ blood
with standard protocols. Array-based CGH was performed
with the Agilent Human Genome CGH Microarray Kits
44K and 244B as previously described6 or the Genechip
Human Mapping 250K Nsp Array (Affymetrix). According
to the manufacturer’s protocols, the Affymetrix array was
stained with the Fluidics Station 450 (Affymetrix) and
scannedwithaGeneChip scanner 30007Gsystem (Affyme-
trix). Copy-number datawere generatedwithin theAffyme-
trix Genotyping Console via the CN4 algorithm with refer-
enceﬁles fromnormal female samplespreviously runon the
system. All possible copy-number alterations greater than
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Figure 1. Analysis of Individuals with Duplications at Xp11.22-11.23
(A) Pedigree of the familial cases (subjects tested for the duplication are numbered) and clinical photographs of affected individuals. The
age of each subject is indicated.
(B–D) Chromosome X aCGH proﬁles (left) and details (right, not enlarged to the same scale) of (B) family 3 II.3, 0.8 Mb duplication; (C)
case 4, recurrent 4.5Mb duplication; and (D) case 5, 6Mb duplication. TheMarch 2006 human reference sequence (NCBI Build 36.1) was
used in all cases. Additional aCGH proﬁles are shown in Figure S1.
(E and F) Interphase FISH veriﬁcation of the direct duplication in (E) case 4 and (F) case 5 (arrowheads). Normal chromosome X signals
are indicated by arrows.We identiﬁed two males and six females (0.33%) with
a microduplication at Xp11.22-p11.23. The rearrangement
was familial in three cases (Figure 1A): one female (family
1, II.1) and one male (family 2, II.1) shared a recurrentThe American4.5 Mb duplication with their affected mother and one
affected sister (Figure 1A; Figure S1); the second male
(family 3, II.3) inherited a smaller duplication (0.8 Mb)
from his unaffected mother (Figures 1A and 1B); threeJournal of Human Genetics 85, 394–400, September 11, 2009 395
additional females carried 4.5 Mb de novo duplications
(cases 4, 8, and 9) (Figure 1C), and two more had partially
overlapping 6 and 9.2 Mb de novo duplications (cases 5
and 6) (Figure 1D).
Informed consent for further molecular and clinical
characterization was obtained from subjects with Xp11.
22-p11.23 duplication, their parents, or their legal tutors.
The screening protocols were approved by all institutional
review boards involved in the research. Genomic DNA
from patients as well as from healthy controls was isolated
from peripheral blood according to standard procedures.
Speciﬁc target sequences were selected for quantitative
PCR (qPCR) analysis with Primer Express software (Applied
Biosystems, Foster City, CA). A control amplicon was
selected with the same parameters in the mitogen-acti-
vated protein kinase 1 (MAPK1 [MIM 176948]) gene on
22q11.2. The UCSC Genome Browser hg18 assembly
(March 2006 human reference sequence, NCBI Build 36.1)
maps and sequence were used as references. All primer
sequences are available on request. Ampliﬁcation and
detection were performed as described6 on an ABI PRISM
7900 Sequence Detection System (Applied Biosystems)
with SYBR Green PCR Master Mix (Applied Biosystems).
No imbalances were detected by qPCR screening of 200
female controls via amplicons centered on the genes
PORCN (MIM 300651), GATA1 (MIM 305371), SHROOM4
(MIM 300579), and BMP15 (MIM 300247).
The presence of an Xp11.22-p11.23 duplication in all
affected individuals and its absence in nonaffected family
members (with the exception of the mother in family 3,
who carries a much smaller duplication) and normal
subjects demonstrate their causal relationship. All affected
individuals (Table S1) show borderline to severe MR and
speech delay. Poor speech articulation and a hoarse and/
or nasal voice were often present. Early puberty was
described in seven of the nine individuals examined, and
six out of 12 were signiﬁcantly overweight. Eight individ-
uals had lower-extremity anomalies, including ﬂat (pes
planus) or arched (pes cavus) feet, ﬁfth-toe hypoplasia,
and syndactily. Case II.3 in family 3, carrying the smallest
duplication, showed mild MR and language delay but no
early puberty, excessive weight gain, or foot anomalies.
In all other affected individuals, clinical features were
apparently independent of sex and duplication size. Five
subjects suffered from rare or isolated seizures. EEG record-
ings showed signiﬁcant diffuse paroxysmal discharges in
six individuals, all less than 15 years old; in ﬁve of them,
discharges were associated with rolandic-like focal parox-
ysms. During wakefulness the discharges, probably related
to secondary bilateral synchrony, were associated with
subclinical absence seizures; during sleep, they became
subcontinuous and produced a typical picture of contin-
uous spike wave during slow sleep (CSWS).7 Subjects in
family 2 presented EEG anomalies with diffuse sharp
wave activities more evident during sleep or drowsiness.
Once again, case II.3 in family 3 had a different EEG
proﬁle, characterized by rolandic-like paroxysms, and396 The American Journal of Human Genetics 85, 394–400, Septemhe showed rare seizures only in the ﬁrst 6 months of his
life.
Paternal origin of the duplication was demonstrated in
all de novo female cases by polymorphic sequence-tagged
site (STS) analysis (Table S2). Genotyping of polymorphic
STSs was performed by ampliﬁcation with primers labeled
with ﬂuorescent probes and subsequent analysis on a ABI
310 Genetic Analyzer (Applied Biosystems, Monza, Italy).
Ampliﬁcations were performed with AmpliTaq Gold (Ap-
plied Biosystems) according to standard protocols. Chro-
mosome X inactivation analysis of affected females,
performed as described8 on a polymorphic region of the
androgen receptor (AR [MIM 313700]) gene, showed selec-
tive inactivation (deﬁned as X-inactivation pattern<20:80
or >80:20) of the normal X chromosome in six subjects
and random inactivation in three subjects (Table S3). The
unaffected carrier mother in family 3 also had random
inactivation. The X-inactivation pattern did not correlate
with duplication size. Within families, in affected subjects
the degree of X-inactivation did not seem to correlate with
clinical phenotype severity.
We deﬁned breakpoint junctions in eight individuals,
including a previously described male with a de novo
4.5 Mb duplication9 (case 7), by qPCR (Table S4) and
long-range PCR ampliﬁcation. For qPCR targets located
in repeated portions of the chromosome, we used a BLAT
search to select regions with signiﬁcant homology to the
target sequence and then performed multiple alignment
with MAP; visual inspection of the aligned sequences al-
lowed us to position the primers in target-speciﬁc regions.
By q-PCR, we were able to narrow most of the breakpoint
regions down to a size (5–10 Kb) amenable to long-range
PCR ampliﬁcation. We performed long-range PCRs with
JumpStart Red ACCUTaq LA DNA polymerase (Sigma) by
using target-speciﬁc primer pairs. Sequencing reactions
were performed with a BigDye Terminator Cycle Se-
quencing kit (Applied Biosystems) and run on an ABI Prism
3130xl Genetic Analyzer.
Direct orientation was conﬁrmed by interphase double-
color Fluorescent in situ hybridization (FISH) (Figures 1E
and 1F). FISH was performed on interphase cells according
to standard procedures. Bacterial artiﬁcial chromosome
(BAC) clones were selected from the human RPCI-11 li-
brary and provided by the BACPAC Resource Center
(BPRC) at the Children’s Hospital Oakland Research Insti-
tute in Oakland, CA. BAC DNAs were labeled either by
biotin-16-dUTP or by digoxigenin with a nick translation
kit (Roche). Double-color FISH was performed with RP11-
8A2 (Xp11.23, AC027819.2 at 48,303,116–48,463,802 bp)
and RP11-576P23 (Xp11.22, AL357894.6 at 50,147,678–
50,302,524 bp) labeled with digoxigenin and biotin, re-
spectively. The labeled probes were visualized with FITC-
avidin (Vector, Burlingame, CA) or Rhodamin-conjugated
anti-digoxigenin (Sigma). Hybridizations were analyzed
with an Olympus BX71 epiﬂuorescence microscope, and
images were captured with the Power Gene FISH System
(PSI, Newcastle upon Tyne, UK).ber 11, 2009
Figure 2. Schematic Structure of the Xp11.22-p11.23 Region
(A) Gaps in the genome assembly, segmental duplications, and Xp11.22-p11.23 duplications are shown. Disease-associated and copy-
number-sensitive genes (not drawn to scale) are described in Table S6. Arrow colors correspond to line colors.
(B) Comparative analysis of the D-REP and P-REP regions performed with Pipmaker software.38 Diagonal plot lines indicate stretches of
sequence identity. The relative positions of chromosome bands, genes, segmental duplications, and copy-number variations are shown.
Breakpoints are indicated by arrows when both are located within the SSX-REPs, and by arrowheads when one breakpoint is outside the
regions shown. Detailed identity plots and junction sequences are shown in Figure S2 and Table S5.The recurrent duplication is ﬂanked distally by a
segmental duplication (D-REP, 47.8–48.2 Mb) containing
a cluster of genes and pseudogenes of the synovial sarcoma
X breakpoint (SSX) and proximally by a complex repeat
(P-REP, 52.1–53.1 Mb) rich in SSX, melanoma antigen
(MAGE), and X antigen (XAGE) genes (Figure 2). Compar-
ative analysis shows that their homology is limited to
300 Kb D-REP and 200 Kb P-REP regions containing SSX
genes (Figure 2B). An additional segmental duplication
rich in G-antigen (GAGE) genes (M-REP, 49.0–49.2 Mb)
shows no homology with either D-REP or P-REP.
Sequence analysis of the junctions demonstrated that
recurrent 4.5 Mb duplications are mediated by nonallelic
homologous recombination (NAHR) or Alu-mediated re-
combination (Table S5 and Figure S2). Alu repeats also
mediate the rearrangements in family 3 and case 5, for
whom only one breakpoint maps to a complex repeat.
Unlike other rearrangements caused by NAHR,10 Xp11.
22-11.23 duplication breakpoints do not cluster in deﬁned
hot spots.
Xp11.2 is a gene-rich, rearrangement-prone region
within the critical linkage interval for several neurogenetic
disorders harboring MRX genes.11 All genes in the region,
with the exception of a small cluster between 53.0 and
53.3 Mb, undergo X inactivation.12
Although X-inactivation pattern and clinical ﬁndings
may be variable,11 most females with chromosome X
duplications are phenotypically normal because skewed
X inactivation selectively inactivates the duplicated chro-The Americanmosome. On the contrary, in most females with Xp11.
22-p11.23 duplication, the duplicated X chromosome is
preferentially active, probably contributing to their clinical
phenotype and suggesting that increased expression of
a duplicated genemight act as a selective factor on dividing
cells.
To our knowledge, only two cases with a recurrent
4.5 Mb duplication at Xp11.22-p11.23 have been reported:
our case 7,9 and one female with mild MR, language delay,
repetitive behavior, and severe hypotonia13 (case SK0306-
004); the latter was detected in a group of families with
simplex and multiplex autism spectrum disorders (ASD
[MIM 209850]). To our knowledge, Xp11.22-p11.23 du-
plications have never been reported as copy-number
polymorphisms in any published study. Additional poly-
morphic variations and pathogenic microdeletions and
microduplications, probably facilitated by the complex
pattern of direct and inverted repeats in the segmental
duplications14, have been described in regions adjacent
to both D-REP and P-REP.4,15,16
Interestingly, a de novo 3.1 Mb duplication between
M-REP and P-REP (49.0–52.1 Mb) was described in a girl
(case 3 in Froyen et al.4) with moderate MR, speech delay,
stereotypic movements, autistic features, no reported EEG
abnormalities, and random X inactivation. Three of the
eight genes (not counting SSX, MAGE, GAGE, and XAGE)
contained in the duplicated region are involved in known
inherited diseases (Figure 2A and Table S6); SHROOM4
[MIM 300579] is an MRX gene.17 In the affected male ofJournal of Human Genetics 85, 394–400, September 11, 2009 397
our family 3, a nonoverlapping 0.8 Mb duplication
between 48.1 and 48.9 Mb, associated with X-linked reces-
sive MR, speech delay, and EEG abnormalities, contains at
least six genes involved in known diseases, including
MRX genes FTSJ1 [MIM 300499]18,19 and Polyglutamine-
binding protein 1 (PQBP1 [MIM 300463]).20–23 The region
between 48.1 and 52.6 Mb is duplicated in our subjects
with recurrent Xp11.22-p11.23 duplication associated
with dominant MR, speech delay, early puberty, foot
anomalies, speciﬁc EEG pattern, seizures, and EEG parox-
ysms limited by pediatric age. A 0.1 Mb sequence between
48.9 and 49.0 Mb, excluded from both 0.8 Mb and 3.1 Mb
duplications, contains the Synaptophysin gene (SYP
[MIM 313475]), involved in MRX and epilepsy.3 Overex-
pression of the bone morphogenetic protein 15 (BMP15
[MIM 300247]) gene, selectively expressed in ovaries24
and mutated in premature ovarian failure (POF4 [MIM
300510]),25,26 could be responsible for early puberty in
these patients. The duplications in cases 5 and 6 encom-
pass a further region between 52.6 and 54.0Mb containing
eight genes; lysine-speciﬁc demethylase 5C (KDM5C [MIM
314690]),27 HSD17B10 (MIM 300256)28,29, and HUWE1
(MIM 300697)30 are MRX genes. The duplication in case
6 spans the largest region and contains at least 30 addi-
tional genes. Among them, Synapsin 1 (SYN1 [MIM
313440]),31 PHF8 (MIM 300560)32,33, and FGD1 (MIM
300546)34,35 are associated with X-linked MR. The recip-
rocal Xp11.22-11.23 deletion has never been found and
is probably not viable.
The phenotype of all subjects with recurrent 4.5 Mb and
nonrecurrent larger duplications is remarkably similar
despite the widely different number of genes, including
MRX genes, involved, pointing to a key role of gene(s) in
the common duplicated region in the deﬁning clinical
features of the syndrome. On the other hand, the level of
MR can vary between borderline and severe, even in
subjects with duplications of the same size and an identical
X-inactivation pattern; behavioral signs can include
shyness, stubbornness, autistic-like symptoms, or ASD as
in the subject in Marshall et al.13. The EEG ﬁndings appear
particularly suggestive for their pattern of secondary bi-
synchronism associated with atypical absences during
wakefulness and continuous spike-wave pattern during
sleep, persisting during adolescence even in the absence
of clear epileptic seizures. Seizures and EEG paroxysms
could be a prerogative of pediatric age; therefore, negative
EEG results in adulthood cannot exclude the presence of
EEG paroxysms in preadolescence. These ﬁndings appear
to be so speciﬁc that it might be tempting to suggest
a search for Xp11.22-p11.23 duplication in subjects with
MR and speech delay associated with continuous spike
waves during sleep, regardless of the presence of seizures.
The analysis of selected patients with borderline to
severe MR, language delay, minor facial dysmorphic
features, and a peculiar EEG pattern characterized by rolan-
dic-like spikes and/or CSWS in the absence of obvious
seizures will probably reveal additional cases of Xp11.22-398 The American Journal of Human Genetics 85, 394–400, Septemp11.23 microduplication and demonstrate that the fre-
quency of 0.33% we calculated was an underestimation.
A similar experimental approach has recently yielded
a prevalence of 0.64% for a recurrent 17q21.31 microdele-
tion in subjects with unexplained MR,36 and 2% of male
subjects with MR and progressive neurological symp-
toms37 carry Xq28 duplications, including that of methyl-
CpG-binding protein 2 (MECP2 [MIM 300005]). It is also
likely that genome-wide aCGH screening in patients with-
out an obvious ‘‘chromosomal phenotype’’ will uncover
new additional microdeletion and microduplication syn-
dromes.
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